BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company, is focused on utilizing its innovative and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics. Currently, the company is developing formulations of pharmaceuticals primarily targeted at treatment opportunities in areas such as pain and infections. For further information, visit the Company’s web site at www.biodeliverysciences.com.
- 18 years ago
QualityStocks
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
Tags Rodman & Renshaw
Related Post
-
Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
In the United States alone, close to one million people are living with MS, with…
-
Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step
California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…
-
Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership
The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…